The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Computational features of tumor-infiltrating lymphocyte architecture of residual disease after chemotherapy on H&E images as prognostic of overall and disease-free survival for triple-negative breast cancer.
 
Germán Corredor
No Relationships to Disclose
 
Paula Toro
No Relationships to Disclose
 
Cheng Lu
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Shaveta Vinayak
Consulting or Advisory Role - Tesaro
Research Funding - OncoSec (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - OncoSec; OncoSec; Oncosec
 
Miluska Castillo Garcia
No Relationships to Disclose
 
Luis A. Bernabe
No Relationships to Disclose
 
Carlos Arturo Castaneda Altamirano
No Relationships to Disclose
 
Alberto J. Montero
Honoraria - Celgene
Consulting or Advisory Role - New Century Health; Welwaze
 
Aparna Harbhajanka
No Relationships to Disclose
 
Hannah L. Gilmore
No Relationships to Disclose
 
Anant Madabhushi
Leadership - Inspirata
Stock and Other Ownership Interests - Elucid Bioimaging; Inspirata
Honoraria - AstraZeneca; Inspirata
Consulting or Advisory Role - Aiforia; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myers-Squibb (Inst); Inspirata (Inst); Philips Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - IP Licensed by Elucid Bioimaging (Inst); IP licensed by Inspirata Inc. (Inst)